Case Reports Surgical Pathology 2018 Exercise 2:Ipilimumab-Associated Colitis (CSSP1802)

This is an online activity in surgical pathology that offers 2.0 continuing education (CME/SAM/CMLE) credit that can be used to fulfill CC Part II and CMP requirements.

Write a Review

List Price: $20.00
Member Price: $15.00

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Join

Item Details:

Authors
Katrina Krogh, MD
Pathology Resident PGY 3
Guang-Yu Yang, MD, PhD
Professor
Maryam Kherad Pezhouh, MD, MSc
Assistant Professor

Department of Pathology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Primary Audience: Pathologists and Clinical Scientists
Secondary Audience: Residents, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators

Upon completion of this activity, you will be able to:

identify the most frequent causes of colitis;
describe the general mechanism of ipilimumab in the treatment of advanced-stage cancers;
identify common ipilimumab-associated immune-related adverse events;
describe clinical and histologic features of ipilimumab-associated colitis; and
differentiate ipilimumab-associated colitis from its mimics.

View More View Less

Case Reports Surgical Pathology 2018 Exercise 2:Ipilimumab-Associated Colitis (CSSP1802)

Item Details:

Bought This Bought That ...